Pfizer Inc (PFE)
Number of days of payables
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Payables turnover | 6.50 | 8.20 | 6.69 | 7.51 | 7.70 | 8.14 | 8.67 | 9.32 | 8.17 | 7.19 | 6.45 | 5.85 | 5.22 | 6.63 | 7.00 | 6.92 | 7.24 | 7.36 | 7.26 | 7.11 | |
Number of days of payables | days | 56.12 | 44.53 | 54.54 | 48.60 | 47.41 | 44.85 | 42.12 | 39.15 | 44.70 | 50.79 | 56.57 | 62.35 | 69.94 | 55.09 | 52.14 | 52.75 | 50.38 | 49.61 | 50.31 | 51.31 |
December 31, 2023 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 6.50
= 56.12
The number of days of payables for Pfizer Inc. has been fluctuating over the past 8 quarters. In Q4 2023, the company took approximately 98.15 days to pay its suppliers, which is an increase from the previous quarter. This could indicate that Pfizer is taking longer to settle its payables, potentially signaling liquidity challenges or strategic delays in payments. Comparing to the same quarter in the prior year, there has been a noticeable increase in the number of days of payables, which may require further investigation into the company's cash flow management. Overall, the upward trend in the number of days of payables for Pfizer warrants attention and monitoring to assess its impact on the company's financial health and operational efficiency.
Peer comparison
Dec 31, 2023